» Articles » PMID: 35318289

Assessment of Muscle Quantity, Quality and Function

Overview
Date 2022 Mar 23
PMID 35318289
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenia is a syndrome characterized by loss of skeletal muscle mass and strength that can increase the risk of physical disability, chronic conditions such as diabetes mellitus and cardiovascular diseases, and long-term mortality. Sarcopenia adversely affects not only the elderly population, but also young adults. This review provides updated definitions of sarcopenia and recommendations for the assessment of muscle quantity and quality.

Citing Articles

Factors, mechanisms and improvement methods of muscle strength loss.

Wang K, Wang X, Wang Y Front Cell Dev Biol. 2024; 12:1509519.

PMID: 39698495 PMC: 11653071. DOI: 10.3389/fcell.2024.1509519.


Sex differences in upper and lower strength and their association with body composition among university students.

Perez M, Urrejola-Contreras G, Hernandez J, Silva P, Torres-Banduc M Phys Act Nutr. 2024; 28(3):64-71.

PMID: 39501696 PMC: 11540993. DOI: 10.20463/pan.2024.0025.


Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis.

Kim H, Cho Y, Kim M, Kim E, Lee M, Lee W Front Endocrinol (Lausanne). 2024; 15:1327522.

PMID: 39170735 PMC: 11335673. DOI: 10.3389/fendo.2024.1327522.


Non invasive techniques for direct muscle quality assessment after exercise intervention in older adults: a systematic review.

Virto N, Rio X, Mendez-Zorrilla A, Garcia-Zapirain B BMC Geriatr. 2024; 24(1):642.

PMID: 39085773 PMC: 11293103. DOI: 10.1186/s12877-024-05243-3.


Total and segmental phase angle in a cohort of hospitalised patients with COVID-19: mortality prediction and changes throughout hospitalisation.

Estrada-Moya F, Gonzalez-Garay A, Flores-Lopez A, Serralde-Zuniga A Br J Nutr. 2023; 131(8):1397-1404.

PMID: 38149452 PMC: 10950452. DOI: 10.1017/S0007114523002994.


References
1.
Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

2.
Malmstrom T, Miller D, Simonsick E, Ferrucci L, Morley J . SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016; 7(1):28-36. PMC: 4799853. DOI: 10.1002/jcsm.12048. View

3.
Jang H . Sarcopenia, Frailty, and Diabetes in Older Adults. Diabetes Metab J. 2016; 40(3):182-9. PMC: 4929221. DOI: 10.4093/dmj.2016.40.3.182. View

4.
Kim S, Kim M, Won C . Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2017; 19(1):40-45.e1. DOI: 10.1016/j.jamda.2017.07.006. View

5.
Schrauwen-Hinderling V, Kooi M, Hesselink M, Jeneson J, Backes W, van Echteld C . Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia. 2006; 50(1):113-20. DOI: 10.1007/s00125-006-0475-1. View